Suzetrigine
Drug Details
- Generic Name
- Suzetrigine
- Brand Names
- JOURNAVX
- Application Number
- NDA219209
- Sponsor
- Catalent Pharma Solutions, LLC
- NDC Codes
- 4
- Dosage Forms
- TABLET, FILM COATED, POWDER
- Routes
- ORAL
- Active Ingredients
- SUZETRIGINE
Indications and Usage
1 INDICATIONS AND USAGE JOURNAVX is indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. JOURNAVX is a sodium channel blocker indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. ( 1 )